News
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.
10d
Pharmaceutical Technology on MSNFDA free to pursue semaglutide compounders after latest court rulingDespite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...
The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...
Learn more › Ready to transform your body before summer? It’s possible with the ShedRx 4-Week Semaglutide Weight Loss Program. It offers personalized care, telehealth consultations ...
13dOpinion
Montreal Gazette on MSNChristopher Labos: Ozempic’s oral counterpart hasn’t caught on yetThe prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
New Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...
Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results